Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Anne-Sophie Michallet"'
Autor:
Amine Belhabri, Mael Heiblig, Stephane Morisset, Liliana Vila, Clémence Santana, Emmanuelle Nicolas‐Virelizier, Sandrine Hayette, Isabelle Tigaud, Adriana Plesa, Hélène Labussiere‐Wallet, Mohamad Sobh, Anne‐Sophie Michallet, Balsat Marie, Franck‐Emmanuel Nicolini, Yann Guillermin, Fossard Gaëlle, Laure Lebras, Philippe Rey, Lucie Jauffret‐Bertholon, Marie‐Charlotte Laude, Loron Sandrine, Mauricette Michallet
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16929-16944 (2023)
Abstract Background t‐AML occurs after a primary malignancy treatment and retains a poor prognosis. Aims To determine the impact of primary malignancies, therapeutic strategies, and prognostic factors on clinical outcomes of t‐AML. Results A tota
Externí odkaz:
https://doaj.org/article/5ada555af80042d89c8cd782e7628bd6
Autor:
Louise Laloi, Natacha Chaumard Billotey, Pierre‐Yves Dumas, Franciane Paul, Alban Villate, Célestine Simand, Luc Fornecker, Florent Puisset, Sarah Bertoli, Marion Boissard Simonet, Kamel Laribi, Dyhia Houyou, Alberto Santagostino, Claire Michel, Gabrielle Roth Guepin, Elodie Guerineau, Reza Tabrizi, Mathilde Hunault, Aurélien Giltat, Eléonore Kaphan, Claude Bulabois, Elodie Cartet, Clément Rocher, Florence Lachenal, Stéphane Morisset, Christian Récher, Arnaud Pigneux, Amine Belhabri, Mauricette Michallet, Anne‐Sophie Michallet
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7175-7181 (2023)
Abstract Background Recently, the combination of venetoclax plus a hypomethylating agent (HMA; azacitidine ordecitabine) or low‐dose cytarabine (LDAC) showed promise in Phase III trials in previously untreated AML. In France at the time of this stu
Externí odkaz:
https://doaj.org/article/63f3a6ecd43b4f86b0b0537085a06afc
Autor:
Caroline Algrin, Louis Pérol, Elise Chapiro, Lucile Baseggio, Karim Maloum, Catherine Settegrana, Jean-François Lesesve, Justine Siavellis, Alain Delmer, Anne-Sophie Michallet, Emmanuelle Ferrant, Pierre Feugier, Cécile Tomowiak, Annie Brion, David Ghez, Luc-Matthieu Fornecker, Sarah Ivanoff, Stéphanie Struski, Laurent Sutton, Isabelle Radford-Weiss, Virginie Eclache, Christine Lefebvre, Véronique Leblond, Florence Nguyen-Khac, Damien Roos-Weil
Publikováno v:
Haematologica, Vol 108, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/b2abff8bb5904fc89c971c8ade3b86be
Autor:
Thibault Andrieu, Paul Mondière, Pierre-Emmanuel Jouve, Sébastien Dussurgey, Victor Malassigné, Hugo Servanton, Lucille Baseggio, Frédéric Davi, Anne-Sophie Michallet, Thierry Defrance
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Chronic Lymphocytic Leukemia (CLL) is characterized by the progressive accumulation of monoclonal mature B lymphocytes. Autoimmune complications are common in CLL occurring in up to a quarter of all patients during the course of the illness. Etiology
Externí odkaz:
https://doaj.org/article/e78815847d4c4254aef60928fb7253e7
Autor:
Florent Malard, Anne Vekhoff, Simona Lapusan, Francoise Isnard, Evelyne D’incan-Corda, Jérôme Rey, Colombe Saillard, Xavier Thomas, Sophie Ducastelle-Lepretre, Etienne Paubelle, Marie-Virginie Larcher, Clément Rocher, Christian Recher, Suzanne Tavitian, Sarah Bertoli, Anne-Sophie Michallet, Lila Gilis, Pierre Peterlin, Patrice Chevallier, Stéphanie Nguyen, Emilie Plantamura, Lilia Boucinha, Cyrielle Gasc, Mauricette Michallet, Joel Dore, Ollivier Legrand, Mohamad Mohty
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
The combination of chemotherapy and broad-spectrum antibiotics induces gut microbiota (GM) dysbiosis in acute myeloid leukaemia (AML) leading to additional complications. Here, the authors report the efficacy in GM restoration and safety of autologou
Externí odkaz:
https://doaj.org/article/f0565b9c6bfc48c0b52d42791181b41c
Autor:
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, Efstathios Kastritis, Shirley D’Sa, Ramon Garcia-Sanz, Cécile Tomowiak, Bénédicte Hivert, Elise Toussaint, Caroline Protin, Jithma P. Abeykoon, Thomas Guerrero-Garcia, Gilad Itchaki, Josephine M. Vos, Anne-Sophie Michallet, Sophie Godet, Jehan Dupuis, Stéphane Leprêtre, Joshua Bomsztyk, Pierre Morel, Véronique Leblond, Steven P. Treon, Meletios A. Dimopoulos, Prashant Kapoor, Alain Delmer, Jorge J. Castillo
Publikováno v:
Haematologica, Vol 106, Iss 11 (2020)
Histological transformation into diffuse large B-cell lymphoma is a rare complication in patients with Waldenström macroglobulinemia (WM) and is usually associated with a poor prognosis. The objective of this study was to develop and validate a prog
Externí odkaz:
https://doaj.org/article/0931a2c3a1de4a5db0e8afca81e892d7
Autor:
Anne Quinquenel, Thérèse Aurran-Schleinitz, Aline Clavert, Florence Cymbalista, Caroline Dartigeas, Frédéric Davi, Sophie de Guibert, Alain Delmer, Marie-Sarah Dilhuydy, Pierre Feugier, Luc-Matthieu Fornecker, David Ghez, Romain Guieze, Kamel Laribi, Véronique Leblond, Stéphane Leprêtre, Rémi Letestu, Vincent Lévy, Florence Nguyen-Khac, Anne-Sophie Michallet, Cécile Tomowiak, Olivier Tournilhac, Loïc Ysebaert, Xavier Troussard, on the behalf of the FILO-LLC Group
Publikováno v:
HemaSphere, Vol 4, Iss 5, p e473 (2020)
Abstract. As a result of significant recent developments, the management of patients with chronic lymphocytic leukemia (CLL) is changing, and new therapeutic options will continue to emerge in the near future. The recommendations of the French Innova
Externí odkaz:
https://doaj.org/article/09eb754c87c6431b99b76fa1236289e3
Autor:
Anne-Sophie Michallet, Melih Aktan, Wolfgang Hiddemann, Osman Ilhan, Peter Johansson, Kamel Laribi, Balkis Meddeb, Carol Moreno, João Raposo, Anna Schuh, Ali Ünal, Tom Widenius, Alf Bernhardt, Kerstin Kellershohn, Dimitri Messeri, Stuart Osborne, Véronique Leblond
Publikováno v:
Haematologica, Vol 103, Iss 4 (2018)
MABLE investigated the efficacy and safety of rituximab plus bendamustine or rituximab plus chlorambucil in fludarabine-ineligible patients with chronic lymphocytic leukemia. Patients received rituximab plus bendamustine or rituximab plus chlorambuci
Externí odkaz:
https://doaj.org/article/ffd24f20e50d48d1825a40285a4635a3
Autor:
Clémentine Sarkozy, Thierry Molina, Hervé Ghesquières, Anne-Sophie Michallet, Jehan Dupuis, Diane Damotte, Franck Morsschauser, Marie Parrens, Laurent Martin, Peggy Dartigues, Aspasia Stamatoullas, Pierre Hirsch, Bettina Fabiani, Krimo Bouabdallah, Maria Gomes da Silva, Marie Maerevoet, Camille Laurent, Bertrand Coiffier, Gilles Salles, Alexandra Traverse-Glehen
Publikováno v:
Haematologica, Vol 102, Iss 1 (2017)
Mediastinal gray zone lymphoma, B-cell lymphomas with intermediate features between classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma, have not been well described in the literature. We report the clinical characteristics and outcome
Externí odkaz:
https://doaj.org/article/b55af0ff3c88475d98f6a38fefab2e31
Autor:
Anne-Sophie Michallet, Yann Guillermin, Benedicte Deau, Laure Lebras, Stephanie Harel, Sandy Amorin, Claire Reynes, Gilles Salles, Fabien Subtil, Pauline Brice
Publikováno v:
Haematologica, Vol 100, Iss 7 (2015)
Externí odkaz:
https://doaj.org/article/9e66fe691ec1486bb14c47a47da579af